Magnetic functionalized nanoparticles for biomedical, drug delivery and imaging applications SD Anderson, VV Gwenin, CD Gwenin Nanoscale research letters 14 (1), 1-16, 2019 | 220 | 2019 |
Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase P Ball, E Thompson, S Anderson, V Gwenin, C Gwenin European Journal of Pharmaceutical Sciences 127, 217-224, 2019 | 13 | 2019 |
Cell-Penetrating Peptides as a Tool for the Cellular Uptake of a Genetically Modified Nitroreductase for use in Directed Enzyme Prodrug Therapy SD Anderson, RJ Hobbs, VV Gwenin, P Ball, LA Bennie, JA Coulter, ... Journal of Functional Biomaterials 10 (4), 45, 2019 | 7 | 2019 |
Evaluation of two xenobiotic reductases from Pseudomonas putida for their suitability for magnetic nanoparticle‐directed enzyme prodrug therapy as a novel approach to cancer … P Ball, J Halliwell, S Anderson, V Gwenin, C Gwenin MicrobiologyOpen, e1110, 2020 | 4 | 2020 |
The YfkO Nitroreductase from Bacillus Licheniformis on Gold-Coated Superparamagnetic Nanoparticles: Towards a Novel Directed Enzyme Prodrug Therapy Approach P Ball, R Hobbs, S Anderson, E Thompson, V Gwenin, C Von Ruhland, ... Pharmaceutics 13 (4), 517, 2021 | 2 | 2021 |
Harnessing a biocatalyst to bioremediate the purification of alkylglycosides SC Alice J. C. Wahart, Jonathan P. Dolan, Simon D. Anderson, Aisling Ní ... ChemBioChem, 2023 | | 2023 |
The Dinitrobenzamide Mustard Prodrugs, PR-104A and SN27686, for Use in a Novel MNDEPT Cancer Prodrug Therapy Approach P Ball, E Thompson, S Anderson, V Gwenin, A Ashoorzadeh, J Smaill, ... Bioscience Reports, 2023 | | 2023 |
The application of CPPs to improve the cellular uptake of a novel delivery vector for use in directed enzyme prodrug therapy S Anderson Bangor University, 2019 | | 2019 |